Truist Securities Downgrades Point Biopharma Global Inc. to ‘Hold’ Following Eli Lilly’s Acquisition Announcement
PNT Ratings by Stock Target Advisor Analyst Ratings Coverage In a significant development in the pharmaceutical and biotechnology industry, Eli Lilly and…